Welcome to the European Neuroendocrine Tumor Society

Founded in 2004, ENETS is the leading and longest-established society dedicated to improving the diagnosis and treatment of neuroendocrine tumours (NETs). It has over 1,500 members from various medical disciplines, including oncology, endocrinology, gastroenterology, nuclear medicine, pathology, radiology, surgery, and basic/translational science.

Our mission is to raise awareness, advance research, and foster collaboration in the NET field.

ENETS provides accredited educational programmes, including conferences, webinars, and e-learning – designed by experts for healthcare professionals. Our vibrant, multidisciplinary community extends well beyond Europe, united in the goal of improving NET diagnosis, treatment, and care.

Webinar Archive

Missed our recent webinar? No worries! You can catch up on all the valuable insights by watching the recording in our ENETS Webinar Archive. Stay up to date and enhance your knowledge at your own pace.

Discover past webinars

ENETS CoE Preceptorship 2026

The ENETS CoE Preceptorship 2026 grant call is now open! Gain hands-on experience and expert mentorship at an ENETS Center of Excellence.

Deadline: 15 October 2026.

Find out more

EBNENM Examinations 2027

Applications are now open for the EBNENM Examinations 2027. The examinations will take place from 10–12 March 2027 in Milan, Italy, during ENETS 2027.

Deadline: 30 November 2026

Learn more

ENETS Publications

New ENETS Guidance Paper

We are pleased to announce the publication of the ninth ENETS guidance paper in the Journal of Neuroendocrinology, focusing on the diagnosis and management of lung and thymic carcinoids.

This paper provides practical, evidence-graded recommendations, addressing key clinical questions in a structured question-and-answer format. It is freely available open access.

Discover all ENETS guidelines

NENs Policy Recommendations

At the 2024 ENETS Annual Conference, a roundtable discussion brought together physicians, patients and EU policymakers to address key barriers to high-quality NEN care across Europe, aligned with the 2023 ENETS-endorsed publication.

ENETS extends its thanks to all contributors and is pleased to support this important initiative.

Read the policy recommendations

SSTR-PeRForm

ENETS is pleased to share the publication of SSTR-PeRForm in The Lancet Oncology. Developed by ENETS and endorsed by EANM and NANETS, the framework proposes standardised criteria for assessing treatment response using somatostatin receptor (SSTR) PET in patients with neuroendocrine tumours.

We congratulate and thank everyone involved in this important research and are delighted to have supported this significant initiative.

Read the abstract at The Lancet Oncology

Latest Controversies in NEN

A new ENETS position statement was published in the Journal of Neuroendocrinology on 30 September 2026. Part of the Controversies in NEN series, the paper by Stålberg et al. provides expert consensus on the role of liver transplantation in patients with advanced small-intestinal and pancreatic NETs, focusing on patient selection, multidisciplinary assessment and the balance of potential benefits and risks.

The paper is published open access and is freely available to all readers.

Discover ENETS consensus papers

BS & TS Task Force Whitepaper

ENETS is excited to announce the publication of the basic and translational science task force whitepaper: White paper on best practices for translational research in neuroendocrine neoplasms

Published in the Journal of Neuroendocrinology on 28 July 2025.

Read JNE article

MEN1 Task Force Study

ENETS is excited to announce the publication of its MEN1 Task Force study: Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE) — An ENETS MEN1 task force questionnaire study.

Published in the Journal of Neuroendocrinology on 26 November 2024.

Read JNE article

Membership matters

Multidisciplinary is our credo. We welcome all NET-related disciplines and professionals! Learn more about the benefits of becoming an ENETS member.

Learn more

Support ENETS

Any donation made to ENETS charity, no matter what size, will help to support us with our many projects. ENETS wants to ensure that neuroendocrine cancer patients in Europe get a timely diagnosis, the best level of care and ultimately, a cure. Click below to read more.

Donate now

ENETS FACTS

22 Annual Conferences
Since 2004
3 Hybrid conferences from 2022 - 2024
5 Virtual conferences
between 2020 - 2024
1,610 Currently registered members

ENETS News

All newsletters